| S1129 |
SRT1720 HCl
|
SRT1720 HCl is a selective SIRT1 activator with EC50 of 0.16 μM in a cell-free assay, but is >230-fold less potent for SIRT2 and SIRT3. SRT1720 induces autophagy.
|
-
J Cachexia Sarcopenia Muscle, 2025, 16(2):e13771
-
Free Radic Biol Med, 2025, 236:98-115
-
Cell Biol Toxicol, 2025, 41(1):24
|
|
| S1899 |
Nicotinamide (Niacinamide)
|
Nicotinamide, a water-soluble vitamin, is an active component of coenzymes NAD and NADP, and also act as an inhibitor of sirtuins.
|
-
EMBO J, 2025, 44(9):2514-2540
-
Cell Death Dis, 2025, 16(1):160
-
Cell Signal, 2025, 127:111587
|
|
| S2935 |
Nicotinamide Riboside Chloride
|
Nicotinamide Riboside Chloride is the chloride salt form of nicotinamide riboside(NR).NR is a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide(NAD) or NAD+ . Nicotinamide riboside chloride is a crystal form of Nicotinamide riboside (NR) chloride. Nicotinamide riboside chloride increases NAD[+] levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside chloride is used in dietary supplements.
|
-
bioRxiv, 2025, 2025.07.10.663928
-
bioRxiv, 2025, 2025.01.06.631511
-
Front Physiol, 2023, 14:1164287
|
|
| S1396 |
Resveratrol (trans-Resveratrol)
|
Resveratrol has a wide spectrum of targets including cyclooxygenases(i.e. COX, IC50=1.1 μM), lipooxygenases(LOX, IC50=2.7 μM), kinases, sirtuins and other proteins. It has anti-cancer, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects. Resveratrol induces mitophagy/autophagy and autophagy-dependent apoptosis.
|
-
Aging Cell, 2025, e70075
-
Biomed Pharmacother, 2025, 190:118393
-
Breast Cancer Res, 2025, 27(1):186
|
|
| S2391 |
Quercetin (Sophoretin)
|
Quercetin, a natural flavonoid present in vegetables, fruit and wine, is a stimulator of recombinant SIRT1 and also a PI3K inhibitor with IC50 of 2.4-5.4 μM. Quercetin induces mitophagy, apoptosis and protective autophagy. Phase 4.
|
-
Alzheimers Res Ther, 2025, 17(1):176
-
Cell Mol Life Sci, 2025, 82(1):164
-
Virol Sin, 2025, S1995-820X(25)00102-6
|
|
| S1541 |
Selisistat (EX-527)
|
Selisistat (EX 527, SEN0014196) is a potent and selective SIRT1 inhibitor with IC50 of 38 nM in a cell-free assay, exhibits >200-fold selectivity against SIRT2 and SIRT3. Phase 2.
|
-
Adv Sci (Weinh), 2025, 12(5):e2409516
-
Cell Death Dis, 2025, 16(1):548
-
Elife, 2025, 13RP100406
|
|
| S2804 |
Sirtinol
|
Sirtinol is a specific SIRT1 and SIRT2 inhibitor with IC50 of 131 μM and 38 μM in cell-free assays, respectively.
|
-
Drug Des Devel Ther, 2023, 17:563-577
-
Shock, 2023, 60(1):75-83
-
Surg Open Sci, 2023, 12:35-42
|
|
| S8628 |
3-TYP
|
3-TYP (3-(1H-1,2,3-triazol-4-yl) pyridine) is a selective SIRT3 inhibitor which is selective for Sirt3 over Sirt1 and Sirt2. The IC50 values for SITR1, SIRT2, SIRT3 are 88 nM, 92 nM, 16 nM respectively.
|
-
Cell Death Dis, 2025, 16(1):160
-
Mol Med Rep, 2025, 31(5)122
-
Cell Rep, 2024, 43(9):114728
|
|
| S7577 |
AGK2
|
AGK2 is a potent, and selective SIRT2 inhibitor with IC50 of 3.5 μM that minimally affects either SIRT1 or SIRT3 at 10-fold higher levels.
|
-
Cell Mol Life Sci, 2025, 82(1):45
-
Aging Cell, 2025, e70075
-
Cell Mol Gastroenterol Hepatol, 2025, 19(7):101494
|
|
| S8627 |
OSS_128167
|
OSS_128167 (SIRT6-IN-1) is a specific SIRT6 inhibitor with IC50 values of 89, 1578 and 751 μM for SIRT6, SIRT1 and SIRT2, respectively. This compound has anti-viral effect in HBV transcription and replication.
|
-
Front Immunol, 2024, 15:1402834
-
Sci Rep, 2024, 14(1):30924
-
Antioxidants (Basel), 2023, 12(3)714
|
|